10 May 2026
CSIR-NCL produces world's first plant-based mRNA vaccine candidate
UPSC
SSC
Banking
Science
Health
Summary
CSIR-National Chemical Lab (Pune) developed first-in-class plant-derived mRNA vaccine platform. Could be game-changer for cold-chain-free vaccines in tropical countries. Phase 1 trial planned for influenza in 2026.
Why it matters
UPSC GS-3 (S&T, Health). Connect with Atmanirbhar Bharat in pharma, traditional knowledge protection, Bharat Biotech (Covaxin).